What Happened
- On World TB Day (March 24), health observers assessed India's progress toward tuberculosis elimination, noting a 21% reduction in new TB cases between 2015 and 2024 and a 28% reduction in TB deaths over the same period.
- India carries approximately 25% of the global TB burden, with around 2.5–2.6 million cases reported annually, making its trajectory the single most important factor for global TB elimination targets.
- Experts highlighted that climate change is an emerging threat to TB progress — climate-driven malnutrition, overcrowding during extreme weather events, and disruption of health systems are expected to exacerbate TB transmission and worsen treatment outcomes.
- India's 100-Days TB Elimination Campaign (launched December 2024) has screened over 20 crore vulnerable persons and diagnosed over 28 lakh TB patients across 347 districts in 33 states.
- WHO recommended new diagnostic tools on World TB Day 2026, including an AI-assisted chest X-ray interpretation tool and a urine-based point-of-care test, to accelerate detection in high-burden settings.
- The theme for World TB Day 2026 is "Yes! We can end TB" — emphasising both hope and the need for stronger political will and funding.
Static Topic Bridges
India's National TB Elimination Programme: Architecture and Tools
India's National Tuberculosis Elimination Programme (NTEP), formerly the Revised National Tuberculosis Control Programme (RNTCP), aims to eliminate TB — defined as less than 1 case per 100,000 population — by 2025, five years ahead of the global SDG target of 2030. The programme operates through a cascade of screening, diagnosis, treatment, and support mechanisms. Nikshay, a real-time digital platform, tracks every TB patient from notification to treatment completion.
- RNTCP launched: 1992; renamed NTEP in 2020
- India's TB elimination target: By 2025 (compared to WHO's global target of 2030)
- Nikshay digital platform: Tracks 2.63 million TB patients (2024 data); enables real-time monitoring
- Nikshay Poshan Yojana (2018): ₹1,000/month direct benefit transfer to notified TB patients; ₹4,454 crore disbursed to 1.38 crore beneficiaries as of 2024
- Rapid molecular testing network: 9,800+ facilities nationwide; annual testing capacity >14 million; world's largest TB diagnostic network
- Drug susceptibility testing labs: 107 culture and DST laboratories
- TB Mukt Bharat: Campaign framework; target = zero TB deaths, zero new infections, zero suffering
Connection to this news: The 21% incidence reduction since 2015 is a result of NTEP's expanded diagnostic infrastructure and the Nikshay Poshan Yojana — but the pace needs to accelerate significantly to meet the 2025 elimination target, which most experts now concede will be missed.
Tuberculosis: Biology, Drug Resistance, and Treatment
TB is caused by Mycobacterium tuberculosis, primarily affecting the lungs (pulmonary TB) but also capable of affecting other organs (extrapulmonary TB). First-line treatment involves a 6-month regimen of DOTS (Directly Observed Treatment Short-course) using four drugs: isoniazid, rifampicin, pyrazinamide, and ethambutol. Drug-resistant TB (DR-TB) complicates treatment significantly. Multidrug-resistant TB (MDR-TB) is resistant to at least isoniazid and rifampicin; extensively drug-resistant TB (XDR-TB) is resistant to a wider range of drugs.
- DOTS (Directly Observed Treatment Short-course): WHO-endorsed strategy; first-line treatment duration 6 months
- MDR-TB treatment: 18-20 months; BPaL regimen (Bedaquiline + Pretomanid + Linezolid) — newer, shorter DR-TB treatment regimen
- BCG vaccine: Only TB vaccine currently available; highly effective against severe childhood TB but less effective against adult pulmonary TB
- Global TB deaths (2023): ~1.25 million
- India's contribution: ~25% of global cases (~2.5–2.6 million cases/year)
- Latent TB: One-fourth of the world's population is estimated to carry latent M. tuberculosis — the TB reactivation risk is a significant challenge
Connection to this news: Climate change's threat to TB progress operates partly through malnutrition (which suppresses immunity, increasing TB reactivation) and partly through disruption of DOTS adherence during extreme weather events — precisely the weak links in TB treatment cascades.
Climate Change and Infectious Disease: The Emerging Nexus
The Intergovernmental Panel on Climate Change (IPCC) Sixth Assessment Report (2022) confirmed that climate change is already affecting the geographic distribution of vector-borne diseases and worsening conditions for airborne pathogens. For TB specifically, climate-driven food insecurity causes undernutrition — a leading risk factor for TB (undernourished people have 3 times higher TB risk). Heat stress and extreme weather events also displace populations into overcrowded settings, increasing TB transmission. Climate change is therefore a threat multiplier for TB, HIV, and other poverty-linked diseases.
- IPCC AR6 (2022): Confirmed health as a major climate risk sector; called for urgent mitigation and adaptation
- Undernutrition and TB: Malnutrition increases TB risk 3-fold; global warming threatens food security in TB-endemic zones
- Vector expansion: Climate change expands range of mosquitoes (malaria, dengue) and sandflies (leishmaniasis)
- Migration and TB: Extreme weather events cause population displacement, creating dense settlements with poor ventilation — ideal TB transmission conditions
- India's climate vulnerability: Coastal flooding, heat stress in Indo-Gangetic Plain, and drought-driven food insecurity directly threaten the populations most vulnerable to TB
Connection to this news: The recognition that climate change will exacerbate TB's burden links two of India's most significant development challenges — it reinforces why climate adaptation and health system strengthening must be pursued simultaneously, not as separate policy silos.
Key Facts & Data
- India's TB incidence reduction (2015-2024): 21%
- India's TB death reduction (2015-2024): 28%
- India's share of global TB burden: ~25% (~2.5–2.6 million cases/year)
- World TB Day theme 2026: "Yes! We can end TB"
- 100-Day TB Campaign (Dec 2024): Screened 20+ crore, diagnosed 28+ lakh TB patients, 347 districts, 33 states
- Nikshay Poshan Yojana: ₹1,000/month; ₹4,454 crore disbursed to 1.38 crore beneficiaries (since 2018)
- Rapid molecular testing network: 9,800+ facilities; capacity >14 million tests/year
- India's TB elimination target: 2025 (WHO global target: 2030)
- BCG vaccine: Only licensed TB vaccine; most effective for childhood forms